Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4+-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV

Journal of Virology

Volumn 72, Issue 12, 1998, Pages 10029-10035

  McChesney, Michael B ^a,b   Collins, Jennifer R ^a   Lu, Ding ^a   Lu, Xusheng ^a   Torten, Judith ^a   Ashley, Rhoda L ^c   Cloyd, Miles W ^d   Miller, Christopher J ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIGEN SPECIFICITY; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INOCULATION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEXUAL TRANSMISSION; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA MUCOSA; VIREMIA; VIRUS INFECTION; VIRUS ISOLATION;

EID: 0031744018     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.12.10029-10035.1998     Document Type: Article

References (52)

1. Ahmed, R., L. A. Morris, and D. M. Knipe. 1996. Persistence of viruses, p. 219-249. In B. N. Fields, D. M. Knipe, P. Howley, et al. (ed.), Fields Virology. Lippincott-Raven Publishers, Philadelphia, Pa.
2. Brettler, D., M. Somasundaran, A. Forsberg, E. Krause, and J. Sullivan. 1992. Silent human immunodeficiency virus type 1 infection: a rare occurrence in a high-risk heterosexual population. Blood 80:2396-2400.
3. Buchbinder, S., M. Katz, N. Hessol, P. O'Malley, and S. Holmberg. 1994. Long term HIV-1 infection without immunologic progression. AIDS 8:1179-1182.
4. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. Ho. 1995. Virologic and immunologic characterization of long term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
5. Chen, B., K. Saksela, R. Andino, and D. Baltimore. 1994. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J. Virol. 68:654-660.
6. Clerici, M., E. Clark, P. Polacino, I. Axberg, L. Kuller, N. Casey, W. Morton, G. Shearer, and R. Benveniste. 1994. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 8:1391-1395.
7. Clerici, M., and G. Shearer. 1996. Correlates of protection in HIV infection and the progression of HIV infection to AIDS. Immunol. Lett. 51:69-73.
8. Committee on Care and Use of Laboratory Animals. 1996. Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources, National Research Council, Washington, D.C.
9. Dalessio, J., and R. Ashley. 1992. Highly sensitive enhanced chemiluminescence immunodetection method for herpes simplex virus type 2 Western immunoblot. J. Clin. Microbiol. 30:1005-1007.
10. Dandekar, S., A. Beebe, J. Barlough, T. Phillips, J. Elder, M. Torten, and N. Pedersen. 1992. Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats. J. Virol. 66:4040-4049.
11. Daniel, M., N. Letvin, P. Sehgal, G. Hunsmann, D. Schmidt, N. King, and R. Desrosiers. 1987. Long-term persistent infection of macaque monkeys with the simian immunodeficiency virus. J. Gen. Virol. 68:3183-3189.
12. Dittmer, U., T. Nisslein, W. Bodemer, H. Petry, U. Sauermann, C. Stahl-Hennig, and G. Hunsmann. 1995. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. Virology 212:392-397.
13. Dittmer, U., S. Stahl-Hennig, C. Coulibaly, T. Nisslein, W. Luke, D. Fuchs, W. Bodemer, H. Petry, and G. Hunsmann. 1995. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequence of high-dose SIV challenge. J. Gen. Virol. 76:1307-1315.
14. El-Sadr, W., and J. Gettler. 1995. Unrecognized human immunodeficiency virus infection in the elderly. Arch. Intern. Med. 155:184-186.
15. Frenkel, L., J. Mullins, G. Learn, L. Manns-Arcuino, B. Herring, M. Kalish, R. Steketee, D. Thea, J. Nichols, S. Liu, A. Harmache, X. He, D. Muthui, A. Madan, L. Hood, A. Haase, M. Zupancic, K. Staskus, S. Wolinsky, P. Krogstad, J. Zhao, I. Chen, R. Koup, D. Ho, B. Korber, R. Apple, R. Coombs, S. Pahwa, and N. Roberts. 1998. Genetic evaluation of suspected cases of transient HIV-1 infection in infants. Science 280:1073-1077.
16. Haseltine, W. 1989. Silent HIV infections. N. Engl. J. Med. 320:1487-1489.
17. Imagawa, D. T., M. H. Lee, S. M. Wolinsky, K. Sano, F. Morales, S. Kwok, J. J. Sninsky, P. G. Nishanian, J. Giorgi, J. L. Fahey, J. Dudley, B. R. Visscher, and R. Detels. 1989. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N. Engl. J. Med. 320:1458-1462.
18. Le Borgne, S., M. Mancini, R. Le Grand, M. Schleef, D. Dormont, P. Tiollais, Y. Riviere, and M. L. Michel. 1998. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology 240:340-315.
19. Letvin, N., and N. King. 1990. Immunologic and pathologic manifestations of the infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Acquired Immune Defic. Syndr. 3:1023-1040.
20. Li, X. D., B. Moore, and M. W. Cloyd. 1996. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences. Virology 225:196-212.
21. Lohman, B., J. Higgins, M. Marthas, P. Marx, and N. Pedersen. 1991. Development of simian immunodeficiency virus isolation, titration, and neutralization assays which use whole blood from rhesus monkeys and an antigen capture enzyme-linked immunosorbent assay. J. Clin. Microbiol. 29: 2187-2192.
22. Lohman, B., M. McChesney, C. Miller, E. McGowan, S. Joye, K. Van Rompay, E. Reay, L. Antipa, N. Pedersen, and M. Marthas. 1994. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance of pathogenic virus challenge. J. Virol. 68:7021-7029.
23. Lohman, B. L., C. J. Miller, and M. B. McChesney. 1995. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 155:5855-5860.
24. MacGregor, R., G. Dublin, I. Frank, R. Hodinka, and H. Friedman. 1995. Failure of culture and polymerase chain reaction to detect human immunodeficiency virus HIV) in seronegative steady sexual partners of HIV infected individuals. Clin. Infect. Dis. 21:122-127.
25. Marthas, M. (University of California - Davis). 1998. Personal communication.
26. Marthas, M., B. Banapour, S. Sutjipto, M. Siegel, P. Marx, M. Gardner, N. Pedersen, and P. Luciw. 1989. Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus. J. Med. Primatol. 18:311-319.
27. Marthas, M., R. Ramos, B. Lohman, K. Van Rompay, R. Unger, C. Miller, B. Banapour, N. Pedersen, and P. Luciw. 1993. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed using attenuated and pathogenic molecular clones of SIVmac. J. Virol. 67:6047-6055.
28. Marthas, M., S. Sutjipto, J. Higgins, B. Lohman, J. Torten, P. Luciw, P. Marx, and N. Pedersen. 1990. Immunization with a live, attenuated simian immunodeficiency virus (SIV) prevents early disease but not infection in rhesus macaques challenged with pathogenic SIV. J. Virol. 64:3694-3700.
29. Michael, N., A. Brown, R. Voigt, S. Frankel, J. Mascola, K. Brothers, M. Louder, D. Birx, and S. Cassol. 1997. Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection - evidence for highly susceptible human hosts. J. Infect. Dis. 175: 1352-1359.
30. Miller, C., M. Marthas, J. Greenier, D. Lu, P. Dailey, and Y. Lu. 1998. In vivo replication capacity rather than in vitro macrophage tropism predicts efficiency of vaginal transmission of simian immunodeficiency virus (SIV) or simian/human immunodeficiency virus (SHIV) in rhesus macaques. J. Virol. 72:3248-3258.
31. Miller, C., M. Marthas, J. Torten, N. Alexander, J. Moore, G. Doncel, and A. Hendrickx. 1994. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J. Virol. 68:6391-6400.
32. Miller, C., M. McChesney, X. Lu, P. Dailey, C. Chutkowski, D. Lu, P. Brosio, B. Roberts, and Y. Lu. 1997. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J. Virol. 71:1911-1921.
33. Mohamed, O., R. Ashley, A. Goldstein, J. McElrath, J. Dalessio, and L. Corey. 1994. Detection of rectal antibodies to HIV-1 by a sensitive chemiluminescent western blot immunodetection method. J. Acquired Immune Defic. Syndr. 7:375-380.
34. Montagnier, L., C. Brenner, S. Chamaret, D. Guetard, A. Blanchard, J. Martin, G. Pialou, and M. Gougeon. 1997. Human immunodeficiency virus infection and AIDS in a person with negative serology. J. Infect. Dis. 175: 955-959.
35. O'Neil, L. L., M. J. Burkhard, L. A. Obert, and E. A. Hoover. 1997. Regression of feline immunodeficiency virus infection. AIDS Res. Hum. Retroviruses 13:713-718.
36. Pantaleo, G., S. Menzo, M. Vaccarezza, C. Graziosi, O. Cohen, J. Demarest. D. Montefiori, J. Orenstein, C. Fox, L. Schrager, J. Margolick, S. Buchbinder, J. Giorgi, and A. Fauci. 1995. Studies in subjects with long term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:209-216.
37. Pauza, C., P. Emau, M. Salvato, P. Trivedi, D. MacKenzie, K. Schultz, and M. Malkovsky. 1993. Pathogenesis of SIVmac251 after atraumatic inoculation of the rectal mucosa in rhesus monkeys. J. Med. Primatol. 22:154-161.
38. Putkonen, P., B. Makitalo, D. Bottinger, G. Biberfeld, and R. Thorstensson. 1997. Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission. J. Virol. 71:4981-4984.
39. Race, E., K. Ramsey, H. Lucia, and M. Cloyd. 1991. Human immunodeficiency virus infection elicits early antibody not detected by standard tests: implications for diagnostics and viral immunology. Virology 184:716-722.
40. Reimer, L., S. Mottice, C. Schable, P. Sullivan, A. Nakashima, M. Rayfield, R. Den, and C. Brokopp. 1997. Absence of detectable antibody in a patient infected with human immunodeficiency virus. Clin. Infect. Dis. 25:98-100.
41. Rota, P. A., A. S. Khan, E. Durigon, T. Yuran, Y. S. Villamarzo, and W. J. Bellini. 1995. Detection of measles virus RNA in urine specimens from vaccine recipients. J. Clin. Microbiol. 33:2485-2488.
42. Rowland-Jones, S., and A. McMichael. 1995. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr. Opin. Immunol. 7:448-455
43. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59-64.
44. Salvato, M., P. Emau, M. Malkovsky, K. Schultz, E. Johnson, and C. Pauza. 1994. Cellular immune responses in rhesus macaques infected rectally with low dose simian immunodeficiency virus. J. Med. Primatol. 23:125-130.
45. Shibata, R., C. Siemon, T. Rizvi, T. Matano, W. Satterfield, H. Lane, and M. Martin. 1997. Reactivation of HIV type 1 in chronically infected chimpanzees following xeno stimulation with human cells or with pulses of corticosteroid. AIDS Res. Hum. Retroviruses 13:377-381.
46. Sutjipto, S., N. C. Pedersen, C. J. Miller, M. B. Gardner, C. V. Hanson, A. Gettie, M. Jennings, J. Higgins, and P. A. Marx. 1990. Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. J. Virol. 64:2290-2297.
47. Trivedi, P., D. Horejsh, S. Hinds, M. Wu, M. Salvato, and C. Pauza. 1996. Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia. J. Virol. 70:6876-6883.
48. Unger, R., M. Marthas, E. Pratt-Lowe, P. Padrid, and P. Luciw. 1992. The nef gene of simian immunodeficiency virus SIVmacA11. J. Virol. 66:5432-5442.
49. Van Rompay, K., M. Marthas, J. Lifson, C. Berardi, G. Vasquez, E. Agatep, Z. Dehqanzada, K. Cundy, N. Bischofberger, and N. Pedersen. 1998. Administration of 9-{2-(phosphonomethoxy)-propyl}adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques. AIDS Res. Hum. Retroviruses 14:761-773.
50. Venet, A., I. Bourgault, A. Aubertin, M. Kieny, and J. Levy. 1992. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virus (SIV) in SIV infected macaques. J. Immunol. 148:2899-2908.
51. Whatmore, A., N. Cook, G. Hall, S. Sharpe, E. Rud, and M. Cranage. 1995. Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J. Virol. 69:5117-5123.
52. Zhou, W., A. Lackner, M. Simon, I. Durand-Gasselin, P. Galanaud, R. Desrosiers, and D. Emilie. 1997. Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy. J. Virol. 71:1227-1236.